Click a link below to view the mailing archive as if it had been sent to you.
| 2014-05-31 12:15 | | Teva Pharma: Underpriced And Misunderstood, Identifiable Catalyst and more... |
| 2014-05-31 00:15 | | Valeant ups the ante for Allergan instead of waiting for rejection |
| 2014-05-30 12:15 | | AstraZenecaâ?Ç?Ös resistance efforts rely on cancer drug advances and more... |
| 2014-05-25 12:15 | | AstraZeneca on brink of victory as Pfizer deadline set to expire and more... |
| 2014-05-25 00:15 | | Healthcare Companies Have Significant Opportunity to Gain Customer Loyalty of Hispanics, Reports PwC's Health Research I... and more... |
| 2014-05-24 12:15 | | Healthcare Companies Have Significant Opportunity to Gain Customer Loyalty of Hispanics, Reports PwC's Health Research I... and more... |
| 2014-05-23 12:15 | | Teva Doomsday Scenario Seen Averted as Patients Switch and more... |
| 2014-05-23 00:15 | | BlackRock Is Said to Encourage Pfizer-AstraZeneca Talks |
| 2014-05-22 12:15 | | Novartis, Boehringer vie for COPD market share with combo meds and more... |
| 2014-05-21 12:15 | | Alnylam announces publication of pre-clinical results with ALN-AS1 and more... |
| 2014-05-21 00:15 | | Takeda Denies Hiding Diabetes Drug Risks in Nevada Trial and more... |
| 2014-05-20 12:15 | | Ophthotech deal with Novartis leaves Fovista well-positioned, says Stifel and more... |
| 2014-05-20 00:15 | | Pfizer said to hope to rekindle AstraZeneca deal before deadline, FT says |
| 2014-05-19 12:15 | | How did AstraZeneca make the Pfizer bid a Harry vs. Voldemort story? and more... |
| 2014-05-19 00:15 | | Pfizer ups offer for AstraZeneca again, to $119B |
| 2014-05-18 12:15 | | Could a Vaccine-Based Cancer Cure Be Around the Corner? and more... |
| 2014-05-17 12:15 | | Takeda phase 3 trial data shows orteronel plus prednisone improved progression free survival in men with chemotherapy and more... |
| 2014-05-17 00:15 | | Valeant to consider breakup after mega deals -investors |
| 2014-05-16 12:15 | | Biotech Bad News Buys and more... |
| 2014-05-13 12:15 | | Sanofi steps up meningitis marketing amid lagging Menactra sales and more... |
| 2014-05-13 00:15 | | Pfizer Says Too Soon to Talk About U.S. AstraZeneca Jobs and more... |
| 2014-05-12 12:15 | | Allergan CEO says 'rumor mill' inconsistent with company history of discreteness and more... |
| 2014-05-11 12:15 | | Immunomedics' (IMMU) CEO Cynthia Sullivan on F3Q 2014 Results - Earnings Call Transcript and more... |
| 2014-05-10 12:15 | | Plugging leaky blood vessels to save vision and more... |
| 2014-05-09 12:15 | | Horizon Pharma Q1 Beats Street; Guidance Mixed and more... |
| 2014-05-09 00:15 | | J&J /Gilead HCV Combo Drug Filed and more... |
| 2014-05-08 12:15 | | GTx says current POWER trials data insufficient to support filing NDA and more... |
| 2014-05-08 00:15 | | Allergan Reports Strong Q1 While Weighing Valeant Bid and more... |
| 2014-05-07 12:15 | | Cell Therapeutics: Enticing To All, Convincing To None and more... |
| 2014-05-07 00:15 | | Bayerâ?Ç?Ös $14.2 Billion Merck Buy Exposes Strategy Split and more... |
| 2014-05-06 12:15 | | AstraZeneca Lays Out Sales Targets to Fight Pfizer Bid and more... |
| 2014-05-06 00:15 | | Bristol-Myers' armed antibody partner Ambrx shoots for an $86M IPO and more... |
| 2014-05-05 12:15 | | Pfizer's 'weak' Q1 numbers bolster case for AZ buy--and post-merger split, too and more... |
| 2014-05-03 12:15 | | Sun Pharma to close its Detroit facility and more... |
| 2014-05-02 12:15 | | Amid Zohydro controversy, Teva, Purdue and Pfizer race ahead with new pain drugs and more... |
| 2014-05-02 00:15 | | Vertex's Sales Plunge 64% as It Refocuses Its Pipeline on Cystic Fibrosis Therapies and more... |
